Home » Reports » Broker Ratings » AstraZeneca plc 8% Potential Upside Indicated by Kepler Cheuvreux

AstraZeneca plc 8% Potential Upside Indicated by Kepler Cheuvreux

AstraZeneca plc with EPIC/TICKER (LON:AZN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ this morning by analysts at Kepler Cheuvreux. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Kepler Cheuvreux have set their target price at 6100 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 8.0% from today’s opening price of 5650 GBX. Over the last 30 and 90 trading days the company share price has decreased 339 points and increased 278 points respectively. The 52 week high for the stock is 6126.4 GBX while the year low stock price is currently 4544.5 GBX.

AstraZeneca plc has a 50 day moving average of 5,732.69 GBX and a 200 day moving average of 5,215.33. There are currently 1,266,779,486 shares in issue with the average daily volume traded being 2,209,258. Market capitalisation for LON:AZN is £71,355,355,024 GBP.

Join us on our new LinkedIn page

Follow us on LinkedIn